Managed Account Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Managed Account Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$503M	Buy	7,553,613 +637,961	+9%	+$42M	0.41%	53
2015 Q1	$446M	Buy	6,915,652 +214,403	+3%	+$13.4M	0.39%	60
2014 Q4	$396M	Sell	6,701,249 -486,779	-7%	-$27.5M	0.39%	55
2014 Q3	$368M	Buy	7,188,028 +81,799	+1%	+$4.09M	0.41%	48
2014 Q2	$345M	Buy	7,106,229 +285,853	+4%	+$14.1M	0.41%	40
2014 Q1	$354M	Sell	6,820,376 -3,370,844	-33%	-$179M	0.46%	34
2013 Q4	$542M	Buy	10,191,220 +548,007	+6%	+$27.9M	0.73%	13
2013 Q3	$446M	Sell	9,643,213 -470,829	-5%	-$20.7M	0.65%	16
2013 Q2	$452M	Buy	+10,114,042	New	+$439M	0.7%	18

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Managed Account Advisors's BMY Position: Q2 2015 in Review

Managed Account Advisors increased its Bristol-Myers Squibb (BMY) stake by 9.2% in Q2 2015, buying an estimated $42M and bringing the position to 7,553,613 shares worth $503M. The position accounts for 0.41% of the portfolio, ranked #53.

Managed Account Advisors first reported a position in BMY in Q2 2013 and has held it in 9 quarters since. The position peaked at $542M in Q4 2013. 1,447 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

Managed Account Advisors held 7,553,613 shares of Bristol-Myers Squibb worth $503M as of Q2 2015.
Managed Account Advisors bought 637,961 Bristol-Myers Squibb shares in Q2 2015, an estimated $42M.
Bristol-Myers Squibb made up 0.41% of Managed Account Advisors's portfolio in Q2 2015, its #53 holding.
Managed Account Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Bristol-Myers Squibb position peaked at $542M in Q4 2013.
1,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.